Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'

Fairly new to the market, Hims & Hers seems to have hit its stride this year, seeing major gains after an earnings beat in February where management gave bullish guidance. The company reported another solid quarter in May, and shares popped a few weeks later when it announced it would begin offering compounded GLP-1 weight loss injections at lower prices than the branded medication. The stock is currently up more than 126% year-to-date. "While it makes sense that the stock roared on this compounded GLP-1 ne ...